Ftse Mib
33.235,42
-0,24%
DAX
18.067,91
-0,31%
S&P 500
5.487,03
0,25%
NASDAQ
17.862,23
0,03%
Bitcoin
64.811,89
-0,50%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Europa EU PHAXIAM Therapeutics SA (PHXM) PHAXIAM Therapeutics SA (PHXM) Notizie

PHXM

PHAXIAM Therapeutics (PHXM)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:EU:PHXM
DataOraFonteTitoloSimboloCompagnia
12/06/202408:00GlobeNewswire Inc.Lancement d'une augmentation de capital avec maintien du DPS d’un montant d’environ 10 M€, susceptible d’être porté à environ 11,5 M€ en cas d’exercice intégral de la clause d'extensionEU:PHXMPHAXIAM Therapeutics SA
07/06/202417:45GlobeNewswire Inc.PHAXIAM annonce les modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 28 juin 2024EU:PHXMPHAXIAM Therapeutics SA
07/06/202417:45GlobeNewswire Inc.PHAXIAM announces the availability of the preparatory documents for the Combined General Meeting of 28 June 2024EU:PHXMPHAXIAM Therapeutics SA
05/06/202418:00GlobeNewswire Inc.Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 mai 2024EU:PHXMPHAXIAM Therapeutics SA
05/06/202418:00GlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital – May 31, 2024EU:PHXMPHAXIAM Therapeutics SA
15/05/202417:45GlobeNewswire Inc.PHAXIAM Therapeutics fait le point sur ses activités et publie l’information financière du premier trimestre 2024EU:PHXMPHAXIAM Therapeutics SA
15/05/202417:45GlobeNewswire Inc.PHAXIAM provides Business and Financial Update for the First Quarter of 2024EU:PHXMPHAXIAM Therapeutics SA
03/05/202418:05GlobeNewswire Inc.Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 30 avril 2024EU:PHXMPHAXIAM Therapeutics SA
03/05/202418:05GlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital – April 30, 2024EU:PHXMPHAXIAM Therapeutics SA
15/04/202407:30GlobeNewswire Inc.PHAXIAM Therapeutics announces enrolment of the first patient in the phase 1 study for the treatment of endocarditis infections caused by Staphylococcus aureusEU:PHXMPHAXIAM Therapeutics SA
15/04/202407:30GlobeNewswire Inc.PHAXIAM Therapeutics annonce le recrutement du premier patient dans l’étude de phase 1 dans l’endocardite infectieuse causée par le Staphylococcus aureusEU:PHXMPHAXIAM Therapeutics SA
09/04/202418:00GlobeNewswire Inc.Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 29 mars 2024EU:PHXMPHAXIAM Therapeutics SA
09/04/202418:00GlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital – March 29, 2024EU:PHXMPHAXIAM Therapeutics SA
05/04/202418:00GlobeNewswire Inc.PHAXIAM Therapeutics announces filing of its 2023 Universal Registration Document (URD)EU:PHXMPHAXIAM Therapeutics SA
05/04/202418:00GlobeNewswire Inc.PHAXIAM Therapeutics annonce le dépôt de son Document d’Enregistrement Universel (URD) 2023EU:PHXMPHAXIAM Therapeutics SA
11/03/202407:00GlobeNewswire Inc.PHAXIAM Therapeutics annonce la réalisation du retrait volontaire de ses « American Depository Shares » du Nasdaq Stock MarketEU:PHXMPHAXIAM Therapeutics SA
11/03/202407:00GlobeNewswire Inc.PHAXIAM Therapeutics announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock MarketEU:PHXMPHAXIAM Therapeutics SA
05/03/202418:00GlobeNewswire Inc.Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 29 février 2024EU:PHXMPHAXIAM Therapeutics SA
05/03/202418:00GlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital - February 29, 2024EU:PHXMPHAXIAM Therapeutics SA
20/02/202422:05GlobeNewswire Inc.PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital MarketEU:PHXMPHAXIAM Therapeutics SA
20/02/202422:05GlobeNewswire Inc.PHAXIAM Therapeutics annonce son intention de procéder au retrait volontaire de ses « American Depositary Shares » du Nasdaq Capital MarketEU:PHXMPHAXIAM Therapeutics SA
06/02/202422:05GlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital - January 31, 2024EU:PHXMPHAXIAM Therapeutics SA
06/02/202422:05GlobeNewswire Inc.Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 janvier 2024EU:PHXMPHAXIAM Therapeutics SA
18/01/202422:05GlobeNewswire Inc.PHAXIAM Therapeutics announces its cash position at the end of 2023 and its financial calendar for 2024EU:PHXMPHAXIAM Therapeutics SA
18/01/202422:05GlobeNewswire Inc.PHAXIAM Therapeutics annonce son niveau de trésorerie à fin 2023 et son calendrier financier 2024EU:PHXMPHAXIAM Therapeutics SA
03/01/202422:05GlobeNewswire Inc.Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 décembre 2023EU:PHXMPHAXIAM Therapeutics SA
03/01/202422:05GlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital - December 31, 2023EU:PHXMPHAXIAM Therapeutics SA
06/12/202322:05GlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital - November 30, 2023EU:PHXMPHAXIAM Therapeutics SA
06/12/202322:05GlobeNewswire Inc.Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 30 novembre 2023EU:PHXMPHAXIAM Therapeutics SA
14/11/202322:05GlobeNewswire Inc.PHAXIAM Therapeutics fait le point sur ses activités et publie ses résultats du troisième trimestre 2023EU:PHXMPHAXIAM Therapeutics SA
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:EU:PHXM

La tua Cronologia

ASX
SLB
Stelar Metals
TG
BAJ
Banyan Gold
USOTC
SALM
Salem Media (QX)
NASDAQ
CAAVX
American Funds College 2...
COIN
GHXKRW
GamerCoin
USOTC
LBLPF
Loblaw Companies (PK)
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network